Riggs Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Riggs Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.11M	Buy	+32,905	New	+$1.1M	0.2%	81
2023 Q1	–	Sell	-1,500	Closed	-$13.7K	–	384
2022 Q4	$13.7K	Hold	1,500	–	–	0.01%	196
2022 Q3	$12K	Hold	1,500	–	–	﹤0.01%	208
2022 Q2	$11K	Hold	1,500	–	–	﹤0.01%	201
2022 Q1	$14K	Hold	1,500	–	–	﹤0.01%	217
2021 Q4	$12K	Hold	1,500	–	–	﹤0.01%	236
2021 Q3	$15K	Hold	1,500	–	–	﹤0.01%	215
2021 Q2	$15K	Hold	1,500	–	–	﹤0.01%	221
2021 Q1	$17K	Hold	1,500	–	–	0.01%	195
2020 Q4	$14K	Hold	1,500	–	–	﹤0.01%	191
2020 Q3	$13K	Hold	1,500	–	–	0.01%	132
2020 Q2	$18K	Hold	1,500	–	–	0.01%	142
2020 Q1	$13K	Buy	+1,500	New	+$15.4K	0.01%	159
2019 Q2	–	Sell	-500	Closed	-$7K	–	270
2019 Q1	$7K	Hold	500	–	–	﹤0.01%	189
2018 Q4	$8K	Hold	500	–	–	0.01%	169
2018 Q3	$10K	Hold	500	–	–	﹤0.01%	176
2018 Q2	$12K	Hold	500	–	–	0.01%	173
2018 Q1	$9K	Hold	500	–	–	﹤0.01%	204
2017 Q4	$9K	Hold	500	–	–	﹤0.01%	198
2017 Q3	$9K	Hold	500	–	–	﹤0.01%	199
2017 Q2	$17K	Hold	500	–	–	0.01%	199
2017 Q1	$16K	Hold	500	–	–	0.01%	178
2016 Q4	$18K	Hold	500	–	–	0.01%	163
2016 Q3	$23K	Hold	500	–	–	0.01%	150
2016 Q2	$25K	Hold	500	–	–	0.01%	147
2016 Q1	$27K	Hold	500	–	–	0.02%	132
2015 Q4	$33K	Hold	500	–	–	0.02%	127
2015 Q3	$28K	Hold	500	–	–	0.02%	129
2015 Q2	$30K	Hold	500	–	–	0.01%	145
2015 Q1	$31K	Hold	500	–	–	0.01%	136
2014 Q4	$29K	Hold	500	–	–	0.01%	146
2014 Q3	$27K	Buy	+500	New	+$26.5K	0.02%	143

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Riggs Asset Management's TEVA Position: Q2 2026 in Review

Riggs Asset Management opened a new position in Teva Pharmaceuticals (TEVA) in Q2 2026: 32,905 shares worth $1.11M. The stake represents 0.2% of the portfolio and ranks #81 among its holdings. This is a return to the name: Riggs Asset Management previously reported a position in TEVA as recently as Q4 2022.

Riggs Asset Management first reported a position in TEVA in Q3 2014 and has held it in 32 quarters since. 675 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Riggs Asset Management held 32,905 shares of Teva Pharmaceuticals worth $1.11M as of Q2 2026.
Teva Pharmaceuticals was a new Riggs Asset Management position in Q2 2026.
Teva Pharmaceuticals made up 0.2% of Riggs Asset Management's portfolio in Q2 2026, its #81 holding.
Riggs Asset Management first reported a position in Teva Pharmaceuticals in Q3 2014 and has held it in 32 quarters since.
675 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Riggs Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.